Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pediatric Transplantation|July 30, 2026
Living Donor Liver Transplantation as Salvage Therapy for Steroid-Refractory Chronic Hepatic GVHD Following Allogeneic Hematopoietic Stem Cell TransplantationUrvi Kapoor, Steven J Lobritto, Monica Bhatia
Pediatric Dermatology|November 22, 2020
Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-CDaniel R Mazori, Kristina M Derrick, Urvi Kapoor, et al.
Blood Advances|February 5, 2026
Differential effects of GVHD therapies on intestinal epitheliumAlberto Utrero-Rico, Urvi Kapoor, Brenden Javier Berrios, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 21, 2023
Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left heartsMeaghan J Beattie, Lynn A Sleeper, Minmin Lu, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2024
Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapiesThinh H Nguyen, Prakash Satwani, Deepak Kumar, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Blood|September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapyAaron Etra, Alexandra Capellini, Amin Alousi, et al.
Journal of Clinical Immunology|October 29, 2024
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working PartyHelena Buso, Etai Adam, Peter D Arkwright, et al.
Transplantation and Cellular Therapy|March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHDMuna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.
Pageof 2